A Quality Improvement Project

被引:0
作者
Joy, Julija A. [1 ]
Gunn, Jennie [1 ]
Mulekar, Madhuri S. [1 ]
机构
[1] Univ S Alabama, Mobile, AL USA
关键词
Addiction; CDC Guidelines; Hepatitis C Virus; Opioid Addiction; Substance Use Disorders; C VIRUS-INFECTION; UNITED-STATES; INJECT DRUGS; PEOPLE; HCV;
D O I
10.1097/JAN.0000000000000466
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Purpose: This quality improvement project was introduced at an addiction treatment center to implement the Centers for Disease Control and Prevention's (CDC's) hepatitis C virus (HCV) treatment guidelines and offer anticraving medications to patients to improve standards of care of patients with substance use disorders. Literature Review: Patients with opioid use disorders are at the highest risk of contracting HCV. More than 80% of people in the United States with opioid use disorders who use intravenous drugs have contracted HCV. Despite the high prevalence of HCV, patients at treatment centers are being screened only for HCV antibodies (HCV-AB) and are not receiving the CDC's HCV treatment guidelines. The CDC has treatment recommendations of hepatitis panels, full STD testing, and early follow-up care. Method: This quality improvement project utilized the Plan-Do -Study -Act tool. With the application of Plan -Do -Study-Act, for patients identified with HCV-AB, the established CDC HCV treatment guidelines were followed, and the clinical progress of the implementation of the guidelines was monitored. Chart reviews comparing compliance of guidelines before and after the study were implemented. Participants: A convenience sample of 125 patients were collected, and of these, 32 patients were found to be HCV-AB+. Findings: The findings revealed that 18.75% of patients followed the CDC's HCV recommendations after the quality improvement project compared with 6.25% of patients before the intervention. The number of HIV testing offered increased by 40.00% as a result of the implementation of the project.
引用
收藏
页码:E79 / E83
页数:5
相关论文
共 19 条
  • [1] Identification of hepatitis B and C screening and patient management guidelines and availability of training for chronic viral hepatitis among health professionals in six European countries: results of a semi-quantitative survey
    Bechini, Angela
    Falla, Abby
    Ahmad, Amena
    Veldhuijzen, Irene
    Boccalini, Sara
    Porchia, Barbara
    Levi, Miriam
    [J]. BMC INFECTIOUS DISEASES, 2015, 15
  • [2] Clarifying the Conundrum: Evidence-Based Practice, Quality Improvement, or Research?: The Clinical Scholarship Continuum
    Carter, Eileen J.
    Mastro, Kari
    Vose, Courtney
    Rivera, Reynaldo
    Larson, Elaine L.
    [J]. JOURNAL OF NURSING ADMINISTRATION, 2017, 47 (05): : 266 - 270
  • [3] Centers for Disease Control and Prevention, 2017, Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease
  • [4] Legal changes to increase access to naloxone for opioid overdose reversal in the United States
    Davis, Corey S.
    Carr, Derek
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2015, 157 : 112 - 120
  • [5] The changing epidemiology of hepatitis C virus infection in the United States: National health and nutrition examination survey 2001 through 2010
    Ditah, Ivo
    Ditah, Fausta
    Devaki, Pardha
    Ewelukwa, Oforbuike
    Ditah, Chobufo
    Njei, Basile
    Luma, Henry N.
    Charlton, Michael
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (04) : 691 - 698
  • [6] Hepatitis C testing in substance use disorder treatment: the role of program managers in adoption of testing services
    Frimpong, Jemima A.
    D'Aunno, Thomas
    [J]. SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2016, 11
  • [7] Can hepatitis C virus infection be eradicated in people who inject drugs?
    Grebely, Jason
    Dore, Gregory J.
    [J]. ANTIVIRAL RESEARCH, 2014, 104 : 62 - 72
  • [8] A Window of Opportunity: Maximizing the Effectiveness of New HCV Regimens in the United States With the Expansion of the Affordable Care Act
    Haley, Sean J.
    Kreek, Mary Jeanne
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2015, 105 (03) : 457 - 463
  • [9] Hampton H., 2015, Gastrointestinal Nursing, V13, P17, DOI [10.12968/gasn.2015.13.Sup5.S17, DOI 10.12968/GASN.2015.13.SUP5.S17]
  • [10] Views and experiences of hepatitis C testing and diagnosis among people who inject drugs: Systematic review of qualitative research
    Jones, L.
    Atkinson, A.
    Bates, G.
    McCoy, E.
    Porcellato, L.
    Beynon, C.
    McVeigh, J.
    Bellis, M. A.
    [J]. INTERNATIONAL JOURNAL OF DRUG POLICY, 2014, 25 (02) : 204 - 211